Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Liver Protein MLKL Drives Aging Through Mitochondrial Damage and Cellular SenescenceLongevity & Aging

Liver Protein MLKL Drives Aging Through Mitochondrial Damage and Cellular Senescence

Researchers discovered that MLKL, a protein previously known for its role in inflammatory cell death, has a surprising second job in liver aging. When elevated in liver cells, MLKL doesn't kill them — instead it impairs mitochondria, generates oxidative stress, and triggers cellular senescence, a state where cells stop dividing but pump out inflammatory signals. These senescent cells then release extracellular vesicles that spread the senescent state to neighboring cells, including immune macrophages, amplifying liver inflammation. The findings identify MLKL as a key driver of age-related liver disease and a potential drug target for conditions like fatty liver disease associated with aging.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.